Exacerbation Study

NCT00845728 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3439

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Indacaterol 150 µg
DRUG: Tiotropium

Sponsor

Novartis Pharmaceuticals